文献速递外周动脉疾病

BeBack 穿越导管在慢性肢体威胁性缺血患者动脉慢性完全闭塞中的表现:单中心经验

Performance of BeBack Crossing Catheter in Chronic Total Occlusion in Patients With Chronic Limb-Threatening Ischemia: A Single-Center Experience.
PubMed 文献 · J Endovasc Ther · 2023-10-17

该单中心回顾性研究纳入2015年至2022年间使用BeBack导管行肢体血运重建的72例患者共78次手术,所有患者传统导丝导管技术首次尝试均失败。手术成功率为91%,技术成功率为92.3%,平均踝肱指数(ABI)由术前0.59改善至术后0.95。作者认为BeBack导管为慢性完全闭塞患者提供了可行选择,手术成功率高且并发症率低。

要点

  • 传统导丝导管技术失败后使用BeBack导管,技术成功率92.3%、手术成功率91%。
  • 平均ABI由术前0.59改善至术后0.95。
  • 仅1例患者出现严重即刻不良事件,30天随访内2例需再次干预、3例死亡。

核心结论

  • 作者认为BeBack导管为慢性完全闭塞患者提供了可行选择,手术成功率高且并发症率低。

研究设计与样本

  • 单中心回顾性研究,纳入2015年至2022年间使用BeBack导管行肢体血运重建的72例患者共78次手术;所有患者传统导丝导管技术首次尝试均失败。

主要发现

  • 手术成功率为91%,技术成功率为92.3%。
  • 最常累及的闭塞节段为股动脉和腘动脉。
  • 平均ABI由术前0.59改善至术后0.95。
  • 最常用入路为对侧股动脉入路,BeBack导管使用85次。
  • 仅1例患者出现严重即刻不良事件;30天随访期间2例需再次干预,随访期间3例死亡。

关键数值与推荐

  • 技术成功定义为使用研究器械实现成功再入或病变通过。
  • 手术成功定义为闭塞动脉再通且残余狭窄小于30%,并伴24小时后ABI改善。

临床怎么用

  • 作者认为BeBack导管为慢性完全闭塞患者提供了可行选择,手术成功率高且并发症率低。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To describe a single-center experience in the treatment of chronic limb-threatening ischemia (CLTI) with the application of BeBack catheter (Bentley InnoMed, Germany) in patients with arterial chronic total occlusion (CTO). MATERIALS AND METHODS: A retrospective review of patients who underwent limb revascularizations using the BeBack catheter between 2015 and 2022. All patients had an initial failed attempt using a traditional guidewire and catheter technique. Technical success was considered whenever a successful re-entry or lesion crossing using the study device was achieved. Procedural success was defined as recanalization of the occluded artery with residual stenosis of less than 30%, and improvement in ankle-brachial index (ABI) after 24 hours. A Rutherford score was assigned to each limb and affected anatomical segments and lesion length were documented. Procedural access sites and complications were noted. RESULTS: The study included 72 patients who underwent 78 procedures using the BeBack crossing catheter. Procedural success was achieved in 91% of cases, with a technical success rate of 92.3%. The most frequently involved occluded segments were the femoral and popliteal arteries. The average ABI improved from 0.59 to 0.95 after the procedure. The most used access site was the contralateral femoral, and the BeBack catheter was employed on 85 occasions. Only 1 patient suffered a severe immediate adverse effect, and during the 30-day follow-up period, 2 patients needed reintervention. Unfortunately, 3 patients died during the follow-up period. CONCLUSION: The BeBack catheter offers a viable option for the treatment of patients with chronic total occlusion, with high procedural success and a low complication rate.Clinical ImpactThe BeBack catheter presents a notable advancement for clinicians managing chronic limb-threatening ischemia (CLTI) and arterial chronic total occlusion (CTO), showcasing over 90% procedural and technical success rates in this study. Its adept ability to navigate and recanalize occluded segments provides a robust alternative, especially when traditional techniques falter. This innovation may chane clinical strategies in vascular interventions, offering an efficient and reliable option, thereby potentially enhancing patient outcomes in limb revascularizations.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Cohen I, Raskin D, Barash Y, et al. Performance of BeBack Crossing Catheter in Chronic Total Occlusion in Patients With Chronic Limb-Threatening Ischemia: A Single-Center Experience. J Endovasc Ther. 2023. PMID: 37849280. doi:10.1177/15266028231204264

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。